Please assess the completion status of the following clinical trial:

Trial Title: Treatment for Affect Dimensions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English-speaking~* Low positive affect indexed by less than or equal to 24 on the positive affect subscale of the PANAS (i.e., PANAS-P); and scores of greater than or equal to 11 for depression, greater to or equal to 6 for anxiety, or greater to or equal to 10 for stress on the Depression, Anxiety, and Stress Scale; and scores of greater than or equal to 5 on any Sheehan Disability Scale subscale.~* Willingness to refrain from starting other psychosocial or pharmacological treatments until study completion.~Exclusion Criteria:~* Patient report of serious medical conditions - such as history of serious, uncontrolled medical illness, or instability (including significant cardio-pulmonary disease, organic brain syndrome, seizure disorder, cerebrovascular disease, thyroid dysfunction, and diabetes)~* Active suicidal ideation~* Lifetime history of bipolar disorder, psychosis, mental retardation, or organic brain damage~* Substance abuse in the last 6 months or dependence within last 12 months.~* 11 or more cigarettes per week or nicotine equivalent.~* History of marijuana, cocaine or stimulant use 5-7 times/week or more before age 15 (e.g., amphetamine, cocaine, methamphetamine)~* Pregnancy~* Bupropion, dopaminergic or neuroleptic medication use in the past 6 months~* Heterocyclics and SSRIs are permitted if stabilized (3 months) and PRN benzodiazepines and beta-blockers are permitted but discouraged on laboratory assessment visits~* Refusal of video/audio-taping

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Positive Affect Treatment (Type: EXPERIMENTAL): 15 sessions of psychotherapy designed to augment reward anticipation, reward attainment, and reward learning.
- Negative Affect Treatment (Type: ACTIVE_COMPARATOR): 15 sessions of psychotherapy designed to decrease threat avoidance, threat appraisal and arousal.

Based on this trial design, predict the completion outcome and termination type (if applicable).